Skip to main content
. 2016 Feb 26;5(1):27–34. doi: 10.1159/000443523

Table 5.

Tissue T3/T4 ratio

Group Heart Liver Kidney WAT visceral WAT subcutaneous Brain
Control (n = 8) 20.1 ± 1.9 10.5 ± 0.5 21.7 ± 0.9 9.5 ± 0.6 6.7 ± 0.8 75.3 ± 10.0a
Propylthiouracil (n = 4) 51.4 ± 17.5 66.3 ± 17.5* 27.6 ± 4.9 87.5 ± 7.6** 59.1 ± 17.4** 331.0 ± 97.1**, a
T3 treatment (n = 5) 122.6 ± 49.2** 74.0 ± 34.6* 156.4 ± 51.4** 72.4 ± 17.9** 42.1 ± 11.4** 421.1 ± 59.6**, b
T4 treatment (n = 3) 8.7 ± 0.6 10.1 ± 4.4 15.5 ± 2.2 6.0 ± 1.1 4.3 ± 1.1 20.5 ± 1.7c

Results are expressed as percentages and represent means ± SEM. WAT = White adipose tissue. Two-way ANOVA yielded p < 0.001 for the effect of treatment and p < 0.001 for the effect of tissue. Comparisons between specific groups performed within rows and within columns yielded the results summarized by the following symbols:

*

p < 0.05 versus control;

**

p < 0.01 versus control by Dunnet's post hoc test;

a

p < 0.01 versus any other tissue;

b

p < 0.05 versus liver and p < 0.01 versus any other tissue;

c

p < 0.05 versus heart and p < 0.01 versus WAT by Tukey's post hoc test.